ArticleBioactive materials2027
An adhesive hydrogel enabling spatiotemporal delivery of umbilical cord exosomes for scarless skin regeneration through immunomodulation and ECM remodeling.
Article in Bioactive materials, 2027. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The regenerative repair of full-thickness skin defects remains a formidable clinical challenge, often culminating in pathological scarring because conventional dressings lack the functionality to balance robust adhesion with mechanical compliance and actively direct tissue regeneration. To address this, we propose an adhesive dual-network hydrogel (GelMA-PBA/HANB/HepMA) via the synergistic integration of dynamic boronic ester bonds and photo-triggered imine crosslinking, while serving as a smart depot for sustained delivery of umbilical cord-derived exosomes (uExos). This system orchestrates a pro-regenerative niche by polarizing macrophages to a pro-healing phenotype and enhancing endothelial angiogenesis, thereby accelerating wound closure and re-epithelialization in a mouse full-thickness defect model. Crucially, in a rigorous rabbit ear hypertrophic scar model, treatment significantly reduces the Scar Elevation Index (SEI) and restores a physiological collagen architecture, evidenced by an increased Col III/I ratio and reduced bulge angle. Importantly, uExos promote scarless healing involved in extracellular matrix remodeling and balanced collagen deposition. By strategically combining smart adhesive materials with cell-free exosome therapy, this study offers a promising strategy for regenerative wound healing and scar prevention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.